Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with steps NICE on ensuring greater (a) clarity and (b) transparency in relation to how carer quality of life is considered within its medicines appraisal framework.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) technology appraisal process allows its independent committees to take all health-related costs and benefits, including health-related quality-of-life for carers, and impacts on personal social services, into account. The NICE’s methods are set out in its published health technology evaluations manual, which is available at the following link:
https://www.nice.org.uk/process/pmg36
Evaluations should consider all health effects for patients, and, when relevant, carers. When presenting health effects for carers, evidence should show when a condition is associated with a substantial effect on a carer’s health-related quality of life, and how the technology affects carers. This applies for all therapies, including therapies for rare diseases. NICE appraisals specifically consider health-related quality of life, for both patients and carers, rather than quality of life as a whole.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on ensuring that the Single Technology Appraisal process takes into account the health-related quality-of-life impacts on carers for (a) all and (b) rare disease therapies.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) technology appraisal process allows its independent committees to take all health-related costs and benefits, including health-related quality-of-life for carers, and impacts on personal social services, into account. The NICE’s methods are set out in its published health technology evaluations manual, which is available at the following link:
https://www.nice.org.uk/process/pmg36
Evaluations should consider all health effects for patients, and, when relevant, carers. When presenting health effects for carers, evidence should show when a condition is associated with a substantial effect on a carer’s health-related quality of life, and how the technology affects carers. This applies for all therapies, including therapies for rare diseases. NICE appraisals specifically consider health-related quality of life, for both patients and carers, rather than quality of life as a whole.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase early diagnosis of invasive lobular carcinoma.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster so that more patients, including those with lobular carcinoma, survive this horrible set of diseases. To achieve this, the NHS has delivered an extra 40,000 operations, scans, and appointments each week as the first step to ensuring early diagnosis and faster treatment.
There are multiple NHS initiatives and funding streams across the NHS in England that support the early detection of breast cancer, and many organisations across the health service are involved.
The Department spends £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), with cancer as the largest area of spend at more than £133 million in 2023/24. The NIHR spends more on cancer than any other disease group, reflecting its high priority. These investments in cancer, including lobular breast cancer, are pivotal to informing efforts to improve cancer prevention, treatment, and outcomes.
The forthcoming National Cancer Plan will include further details on improving outcomes for cancer patients, including those with invasive lobular carcinoma, and will highlight how the Department will support the NHS to improve diagnosis rates for people in all parts of England.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department for Transport:
To ask the Secretary of State for Transport, pursuant to the Answer of 15 May 2025 to Question 904123 Gatwick Airport: Carbon Emissions, if she will list the organisations from which she has received carbon emissions projection data relating to Gatwick's proposed expansion.
Answered by Mike Kane - Parliamentary Under-Secretary (Department for Transport)
As this is live planning application that is yet to be decided, unfortunately I cannot comment in detail at this time. However, all information provided to the Secretary of State by the applicant, the Examining Authority, and any parties who chose to make written representations is available on the Planning Inspectorate website. This will include information on carbon emissions.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if she will make an estimate she of the potential impact of changes to (a) PIP entitlement rules, (b) the Universal Credit health element and (c) the Universal Credit standard allowance and (d) all three measures on the number of (i) families, (ii) people and (iii) children who are (A) in and (B) not in relative poverty after housing costs pre-measures in 2029-30, using baselines in which the Autumn Statement 2023 Work Capability Assessment descriptor reforms are assumed to have (1) been implemented and (2) not been implemented.
Answered by Alison McGovern - Minister of State (Department for Work and Pensions)
An assessment of the potential impact of the planned changes to health and disability benefits is available here: Spring Statement 2025 health and disability benefit reforms – Impacts.
This includes breakdowns for each change separately on levels of poverty. It also includes estimated impacts regarding the changes to the Work Capability Assessment descriptors proposed at Autumn Statement 2023, but which were subsequently reversed.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if she will make an estimate of the potential impact of changes to (a) PIP entitlement rules, (b) the Universal Credit health element, (c) Universal Credit standard allowance and (d) all three measures on the number of (i) people and (ii) children who will be in relative poverty after housing costs in 2029-30, using baselines in which the Autumn Statement 2023 Work Capability Assessment descriptor reforms are assumed to have (A) been implemented and (B) not been implemented.
Answered by Alison McGovern - Minister of State (Department for Work and Pensions)
An assessment of the potential impact of the planned changes to health and disability benefits is available here: Spring Statement 2025 health and disability benefit reforms – Impacts.
This includes breakdowns for each change separately on levels of poverty. It also includes estimated impacts regarding the changes to the Work Capability Assessment descriptors proposed at Autumn Statement 2023, but which were subsequently reversed.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what assessment she has made of the potential impact of expanding Gatwick Airport on carbon emissions.
Answered by Mike Kane - Parliamentary Under-Secretary (Department for Transport)
This Government has been clear that airport expansion proposals need to demonstrate they can be delivered in line with the UK’s climate change commitments.
Having received further information from Gatwick, the Secretary of State hopes to make a final decision in due course.
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to issue new guidance on the provision of advanced community eye care services in (a) Horsham and (b) England.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Integrated care boards are responsible for commissioning primary and secondary eye care services in their areas to meet patient needs, and this includes services to meet the needs of patients with glaucoma.
The Department worked with the eye care sector to develop a standard clinical specification for the commissioning of Community Minor and Urgent Eye Care Services, and this was published in February 2024. The specification is available at the following link:
https://locsu.co.uk/wp-content/uploads/2024/02/1.-CUES-Service-specification-vs-1.43-Feb-2024.pdf
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that glaucoma monitoring services are available to patients in (a) Horsham and (b) England.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Integrated care boards are responsible for commissioning primary and secondary eye care services in their areas to meet patient needs, and this includes services to meet the needs of patients with glaucoma.
The Department worked with the eye care sector to develop a standard clinical specification for the commissioning of Community Minor and Urgent Eye Care Services, and this was published in February 2024. The specification is available at the following link:
https://locsu.co.uk/wp-content/uploads/2024/02/1.-CUES-Service-specification-vs-1.43-Feb-2024.pdf
Asked by: John Milne (Liberal Democrat - Horsham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether (a) he and (b) the Minister for Public Health and Prevention will attend the Lobular Moon Shot Project's drop in on Tuesday 6 May 2025 to discuss research into lobular breast cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Due to diary pressures, neither myself nor my Rt Hon. Friend, the Secretary of State for Health and Social Care will be attending the Lobular Moon Shot Project’s drop in event on 6 May 2025. However, the Department will continue to fund research into lobular breast cancer through the National Institute for Health and Care Research (NIHR).
The NIHR welcomes funding applications for research into any aspect of human health and care, including lobular breast cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Welcoming applications on lobular breast cancers to all NIHR programmes enables maximum flexibility both in terms of the amount of research funding a particular area can be awarded, and the type of research which can be funded.